awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36545246-FE183014-88EF-4559-AF20-71F7753F2161
Q36545246-FE183014-88EF-4559-AF20-71F7753F2161
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36545246-FE183014-88EF-4559-AF20-71F7753F2161
GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS axis in hepatocellular carcinoma
P2860
Q36545246-FE183014-88EF-4559-AF20-71F7753F2161
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36545246-FE183014-88EF-4559-AF20-71F7753F2161
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
32f2969276a380c3fefa1cf92c2f146eca5b26e7
P2860
Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.